Longevity & Aging
AI Designs First Inhaled Drug Candidate to Target Pulmonary Fibrosis
Insilico Medicine's AI-generated TNIK inhibitor enters Phase 1 trials for pulmonary fibrosis, signaling a new era in drug discovery.
Press Release
May 20, 2026 0
All Articles
769 articles
Longevity & Aging
FDA Approves First Aldosterone Synthase Inhibitor BAXFENDY to Tackle Resistant Hypertension
AstraZeneca's BAXFENDY cuts systolic blood pressure by nearly 10 mmHg beyond placebo in adults whose BP wasn't controlled by other drugs.
Press Release
May 20, 2026 0
Longevity & Aging
Gut Bacteria Help Melanoma Patients Respond to Immunotherapy Again
A Phase 1b trial shows a daily probiotic capsule may restore immunotherapy response in advanced melanoma patients who had stopped responding.
Press Release
May 20, 2026 0
Longevity & Aging
Blood Sugar Molecules Called Glycans May Predict and Reverse Biological Aging
A 20,000-person study finds IgG glycan patterns track biological aging, predict mortality, and shift toward youth with interventions.
Press Release
May 20, 2026 0
Longevity & Aging
Brain-Targeted GLP-1 Drug Could Shield Aging Minds from Alzheimer's and Parkinson's
A new GLP-1 therapy engineered to cross the blood-brain barrier enters Phase II trials, targeting cognitive decline in Parkinson's and Alzheimer's.
Press Release
May 20, 2026 0
Longevity & Aging
Banked Bone Marrow Could Rebuild Aging Immune Systems at Scale
Ossium Health is banking donor bone marrow for on-demand transplant, targeting immune aging as a future healthspan intervention.
Press Release
May 20, 2026 0
Longevity & Aging
Bacterial Immunotherapy Enters Human Trials for Deadliest Pancreatic Cancer
Matter Bio files first IND for Listeria-based therapy targeting pancreatic cancer, merging oncology and longevity science.
Press Release
May 20, 2026 0
Regenerative Medicine
FDA Approves Baxdrostat as New Option for Hard-to-Treat High Blood Pressure
AstraZeneca's baxdrostat wins FDA approval for hypertension, offering a novel mechanism for patients uncontrolled on existing therapies.
Press Release
May 19, 2026 0
Longevity & Aging
FDA Opens Drug Repurposing Push to Tackle Chronic and Rare Disease Gaps
The FDA is seeking public input on repurposing approved drugs for new uses, targeting metabolic, neurodegenerative, and rare diseases.
Press Release
May 19, 2026 0
Longevity & Aging
FDA Approves Enhertu for Early-Stage HER2+ Breast Cancer in Curative Settings
Trastuzumab deruxtecan wins two new FDA approvals for early HER2+ breast cancer, showing dramatic survival gains over standard therapy.
Press Release
May 19, 2026 0
Longevity & Aging
Darolutamide Plus ADT Cuts Prostate Cancer Progression Risk by 71% in US Trial
A US phase II trial confirms darolutamide combined with ADT dramatically improves survival in metastatic hormone-sensitive prostate cancer.
Press Release
May 19, 2026 0
Longevity & Aging
FDA Approves First-in-Class Blood Pressure Pill That Targets Aldosterone at the Source
Baxdrostat blocks aldosterone production directly, cutting systolic BP by ~15 mmHg in resistant hypertension patients who failed other drugs.
Press Release
May 19, 2026 0